- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Scleroderma, Diffuse in Colombia
Total 147 results
-
George Washington UniversityCompleted
-
Georgetown UniversityCSL BehringUnknown
-
National Institute of Arthritis and Musculoskeletal...Medical University of South Carolina; Johns Hopkins University; University of... and other collaboratorsCompletedConnective Tissue Diseases | SclerodermaUnited States
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN); Seagen...CompletedDiffuse Cutaneous Systemic Sclerosis | Scleroderma | dcSScUnited States
-
Bristol-Myers SquibbWithdrawnSclerodermaUnited Kingdom, United States, Poland, Canada
-
Dinesh Khanna, MD, MSBayerCompletedScleroderma | Digital UlcersUnited States
-
Georgetown UniversityActelionTerminatedSystemic Scleroderma | Pulmonary HypertensionUnited States
-
Bristol-Myers SquibbCompletedSclerodermaUnited States
-
United TherapeuticsCompletedSystemic Sclerosis | SclerodermaUnited States, Canada, United Kingdom
-
Dinesh Khanna, MD, MSBristol-Myers Squibb; National Institute of Allergy and Infectious Diseases...CompletedDiffuse Cutaneous Systemic SclerosisUnited States, Canada, United Kingdom
-
Kadmon, a Sanofi CompanyTerminatedDiffuse Cutaneous Systemic Sclerosis | System; SclerosisUnited States
-
CSL BehringWithdrawnDiffuse Cutaneous Systemic SclerosisBelgium, United States, Italy, Spain, France, Germany, United Kingdom, Argentina, Australia, Canada, Mexico, Poland, Switzerland
-
Universidad de la SabanaFundación Neumologica Colombiana; Stem Medicina Regenerativa; Innocell SASAvailablePulmonary Fibrosis | Pulmonary Hypertension | Systemic Sclerosis PulmonaryColombia
-
Corbus Pharmaceuticals Inc.TerminatedDiffuse Cutaneous Systemic SclerosisUnited States, Switzerland, Korea, Republic of, Australia, Netherlands, Israel, United Kingdom, Germany, Japan, Spain, Poland, Canada
-
Boehringer IngelheimCompletedScleroderma, SystemicUnited States, Spain, United Kingdom, Belgium, Australia, Germany, Israel, China, Malaysia, Japan, Canada, Switzerland, France, Ireland, Greece, Norway, Portugal, Netherlands, Austria, Finland, Chile, Thailand, India, Argentina, Brazil, C... and more
-
Michael RothUniversity of California, Los Angeles; University of Michigan; Genentech, Inc.CompletedScleroderma, Systemic | Interstitial Lung DiseaseUnited States
-
SanofiCompletedSystemic SclerosisItaly, United States, France, Switzerland, United Kingdom
-
Cytori TherapeuticsCompletedSystemic Sclerosis | Scleroderma | Raynaud Phenomena | Raynaud's DiseaseUnited States
-
BayerCompletedScleroderma, SystemicNetherlands, Belgium, United States, Australia, Hungary, United Kingdom, Canada, Germany, Switzerland, France, Italy, Japan, New Zealand, Turkey, Czechia
-
Hoffmann-La RocheCompletedSystemic SclerosisBelgium, United Kingdom, Mexico, Poland, United States, Japan, Argentina, Netherlands, Canada, France, Lithuania, Germany, Spain, Bulgaria, Denmark, Greece, Hungary, Italy, Portugal, Puerto Rico, Romania, Switzerland
-
Michael RothNational Heart, Lung, and Blood Institute (NHLBI); Hoffmann-La RocheCompletedInterstitial Lung Disease | SclerodermaUnited States
-
ActelionCompletedSystemic Sclerosis | UlcersCanada, United States, Belarus, Hungary, Croatia, Australia, Denmark, Ukraine, Bulgaria, Chile, Colombia, Czech Republic, Finland, Germany, India, Italy, Poland, Russian Federation
-
SanofiCompletedSystemic SclerosisUnited States, Argentina, Belgium, Estonia, France, Germany, Italy, Mexico, Poland, Romania, Russian Federation, Ukraine, United Kingdom
-
Genentech, Inc.RecruitingSystemic SclerosisBelgium, United States, Spain, France, Portugal, Germany, United Kingdom, Israel, Poland, Argentina, Puerto Rico, Serbia
-
ActelionCompletedScleroderma, Systemic | Pulmonary FibrosisUnited States, Israel, France, United Kingdom, Netherlands, Switzerland, Germany, Italy, Sweden
-
Hoffmann-La RocheCompletedSclerosis, SystemicGermany, United States, France, United Kingdom, Canada
-
ActelionTerminatedDigital UlcersSpain, United States, Argentina, China, Ireland, Colombia, Israel, New Zealand, Germany, Belgium, Portugal, Netherlands, South Africa, Greece, Mexico, Poland, Puerto Rico, Russian Federation, Turkey, Ukraine, United Kingdom
-
United TherapeuticsTerminatedSystemic SclerosisUnited States, Canada, United Kingdom
-
Scleroderma Research Foundation, Inc.Sanofi; Boehringer IngelheimNot yet recruitingScleroderma | Interstitial Lung Disease Due to Systemic DiseaseUnited States
-
ActelionCompletedInterstitial Lung Disease | SclerodermaUnited States, Korea, Republic of, Israel, France, United Kingdom, Netherlands, Switzerland, Germany, Canada, Italy, Sweden
-
CelgeneTerminatedSystemic Sclerosis | Scleroderma, Systemic | Systemic Scleroderma | Interstitial Lung Disease | Sclerosis, SystemicUnited States, Spain, France, Australia, Italy, Switzerland, Germany, Poland, United Kingdom, Russian Federation
-
AstraZenecaRecruitingSystemic Sclerosis | SclerodermaUnited Kingdom, United States, Italy, Mexico, Belgium, Germany, Spain, China, France, India, Austria, Canada, Poland, Israel, Korea, Republic of, Hungary, Japan, South Africa, Turkey, Netherlands, Romania
-
Georgetown UniversityGilead SciencesCompletedSystemic Sclerosis | Pulmonary Arterial Hypertension | Pulmonary Hypertension | SclerodermaUnited States
-
Boehringer IngelheimRecruitingScleroderma, SystemicUnited States, Belgium, Korea, Republic of, Australia, China, Taiwan, Spain, Israel, Japan, Mexico, Turkey, Germany, Italy, Brazil, France, Singapore, Canada, Philippines, United Kingdom, Switzerland, Finland, Greece, New Zealand, Den... and more
-
MediQuest TherapeuticsUnknownRaynaud's Disease | Raynaud's Disease Secondary to Scleroderma | Raynaud's Disease Secondary to Other Autoimmune DiseaseUnited States
-
Prometheus Biosciences, Inc., a subsidiary of Merck...RecruitingDiffuse Cutaneous Systemic Sclerosis | Interstitial Lung DiseaseUnited States, Australia, Belgium, Canada, France, Germany, Hungary, Israel, Italy, Netherlands, Norway, Poland, Spain, Switzerland, United Kingdom
-
George Washington UniversityAmerican College of Rheumatology Research and Education FoundationCompletedBlood Coagulation Disorders | Connective Tissue Diseases | Rheumatoid Arthritis | Systemic Lupus Erythematosus | Systemic Scleroderma | Leg Ulcers | Mixed Connective Tissue DiseaseUnited States
-
Genentech, Inc.CompletedSystemic SclerosisUnited States, Canada, Italy
-
Eicos Sciences, Inc.CompletedRaynaud Phenomenon Secondary to Systemic SclerosisUnited States
-
Acceleron Pharma, Inc., a wholly-owned subsidiary...Active, not recruitingSystemic Sclerosis With and Without Interstitial Lung DiseaseUnited States, Canada, Italy, Switzerland
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedSystemic Sclerosis-associated Interstitial Lung DiseaseUnited States, Canada, Italy, Poland, Spain, Argentina, Australia, Israel, United Kingdom
-
Eicos Sciences, Inc.CompletedRaynaud's Phenomenon Secondary to Systemic SclerosisUnited States
-
ActelionTerminatedSystemic Sclerosis | Pulmonary Arterial Hypertension | Pulmonary HypertensionUnited States, Canada, Spain, Hungary, Switzerland, Turkey, Germany, Austria, Bosnia and Herzegovina, Brazil, China, Czech Republic, Netherlands, Norway, Poland, Puerto Rico, Romania, Russian Federation, Slovakia, United Kingdom
-
Alpine Immune Sciences, Inc.CompletedMultiple Sclerosis | Systemic Lupus Erythematosus | Systemic Sclerosis | Crohn's Disease | Ulcerative Colitis | Sjogren's Syndrome | Inflammatory MyositisCanada
-
GlaxoSmithKlineRecruitingScleroderma, Systemic | Systemic Sclerosis Associated Interstitial Lung DiseaseUnited States, Australia, France, Italy, Japan, Spain, Belgium, Greece, Korea, Republic of, China, Mexico, United Kingdom, Finland, Israel, Germany, Argentina, Brazil, Canada, Denmark
-
Genentech, Inc.RecruitingIdiopathic Pulmonary Fibrosis | Systemic Sclerosis With Lung InvolvementUnited States, Korea, Republic of, Taiwan, Australia, Spain, Italy, Israel, Belgium, Argentina, France, Brazil, Greece, Poland, Chile, South Africa, Canada, New Zealand
-
David Rizzieri, MDNovartis PharmaceuticalsTerminatedLymphoma, Large-Cell, DiffuseUnited States
-
George Washington UniversityWithdrawnNon-Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | DLBCLUnited States
-
British Columbia Cancer AgencyNational Cancer Institute (NCI)Completed
-
Kymera Therapeutics, Inc.SuspendedNon Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | DLBCL | MYD88 Gene MutationUnited States, United Kingdom